The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular annotation of extramedullary acute myeloid leukemia to identify prevalence of targetable mutations.
Somedeb Ball
No Relationships to Disclose
Todd C Knepper
No Relationships to Disclose
Yehuda Ethan Deutsch
No Relationships to Disclose
Chirag K Bhagat
No Relationships to Disclose
Justin M. Watts
No Relationships to Disclose
Terrence J Bradley
No Relationships to Disclose
Wassim Samra
No Relationships to Disclose
Onyee Chan
No Relationships to Disclose
Mohammad Omar Hussaini
No Relationships to Disclose
Kendra L Sweet
Honoraria - Astellas Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Research Funding - Incyte (Inst)
Chetasi Talati
No Relationships to Disclose
Eric Padron
Honoraria - Blueprint Medicines; Stemline Therapeutics
Speakers' Bureau - Novartis; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Kura Oncology (Inst)
Rami S. Komrokji
Stock and Other Ownership Interests - Abbvie
Consulting or Advisory Role - Abbvie; Acceleron Pharma; Bristol-Myers Squibb; Geron; Jazz Pharmaceuticals; Novartis
Speakers' Bureau - Agios; Bristol-Myers Squibb; Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Agios; Bristol-Myers Squibb; Jazz Pharmaceuticals
Jeffrey E. Lancet
Stock and Other Ownership Interests - Arvinas (I)
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; BerGenBio; Bristol-Myers Squibb/Celgene; Daiichi Sankyo; ElevateBio; Jazz Pharmaceuticals; Millennium; Novartis
Research Funding - Pfizer (Inst)
David Andrew Sallman
Consulting or Advisory Role - Abbvie; Agios; Aprea AB; Bristol-Myers Squibb; Celyad; Gilead Sciences; Intellia Therapeutics; Kite, a Gilead company; Magenta Therapeutics; Novartis; Syndax
Speakers' Bureau - Agios; Bristol-Myers Squibb; Incyte
Research Funding - Celgene; Jazz Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Intellectual Property Patent for LB-100 in MDS